StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
2931.T$355.00-0.56%
Fair $355.00+0.0%

2931.T

Euglena Co., Ltd.

Consumer Defensive / Household & Personal ProductsTokyo

$355.00

-2.00 (-0.56%)

Fairly Valued+0.0%Fair Value $355.00Fund rank 23/100 · Data gapFallback financials|
SA 20/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 19%

FCF escenarios

weak_data · normalized FCF $1.9B · quality 36.3/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 16/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

20/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -2.6%, below the 5% threshold
Thesis & Journal · 2931.TLocal privado en este navegador · Euglena Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$49.4B

P/E

N/A

•

EV/EBITDA

9.6x

↑

ROE

-2.6%

↓

Gross Margin

69.6%

↑

Debt/Equity

0.89

↑
52-Week Range$355
$348$513

TradingView lightweight chart

2931.T price, volumen y niveles de valoración

Último $355.00Periodo +114.9%
Fair value: $355.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+4.3%

FCF CAGR

+120.6%

FCF margin

9.1%

FCF / Net income

-5.71x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $50.37B · net income $-805.0M · FCF $4.59B

2022-FY → 2025-FY

Gross margin

69.6%-0.3% pts

Operating margin

6.2%+14.0% pts

Net margin

-1.6%+4.4% pts

FCF margin

9.1%+8.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$50.37B$50.37B$47.62B$46.48B$44.39B
Net Income$-805.0M$-805.0M$-650.0M$-2.65B$-2.67B
EBITDA$5.70B$5.70B$3.77B$1.34B$1.31B
EPS-5.90-5.90-4.77-22.76-23.83
Gross Margin69.6%69.6%69.9%68.4%69.8%
Operating Margin6.2%6.2%0.6%-3.2%-7.8%
Net Margin-1.6%-1.6%-1.4%-5.7%-6.0%
Balance Sheet
Debt/Equity0.890.890.821.241.15
Current Ratio1.171.17———
Cash Flow
Free Cash Flow$4.59B$4.59B$1.91B$-35.0M$428.0M
Returns
ROE-2.6%-2.6%-2.1%-13.1%-13.8%
Valuation
EV/EBITDA9.649.6416.4167.1089.77
P/B1.561.561.793.985.45
Growth & Yield
Revenue Growth5.8%5.8%2.4%4.7%—
EPS Growth-23.8%-23.8%79.1%4.5%—
Dividend Yield0.6%0.6%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -21.4%

Total return

-21.4%

Start / end P/E

n/dx → n/dx

EPS bridge

-4.77 → -5.90

Residual

-22.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.6%
Residual / FX / buybacks / cross-term-22.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.